BlackBerry stock price target maintained at $4.00 by RBC Capital

Published 22/09/2025, 15:18
© Reuters.

Investing.com - RBC Capital has reiterated its Sector Perform rating and $4.00 price target on BlackBerry Limited (NYSE:BB) ahead of the company’s second-quarter earnings report, scheduled for September 25. According to InvestingPro data, BlackBerry currently trades at $4.30, with a market capitalization of $2.56 billion and a notably high P/E ratio of 250.6.

The firm believes BlackBerry may report Q2 results slightly above both RBC and consensus expectations, citing a more stable macroeconomic environment than what was reflected in the company’s "relatively conservative guidance." InvestingPro analysis shows the company has been profitable over the last twelve months, though 2 analysts have recently revised their earnings expectations downward.

RBC Capital expects BlackBerry to maintain its fiscal year 2026 revenue guidance while potentially raising its FY26 adjusted EBITDA guidance due to "continued cost restraint" measures.

The firm maintained its Sector Perform rating on BlackBerry stock, noting that the company’s valuation will likely "remain discounted pending improved visibility to sustained growth."

BlackBerry is expected to report its second-quarter financial results in the coming weeks, though no specific date was mentioned in the analyst’s commentary.

In other recent news, BlackBerry Limited has announced a partnership between its QNX division and NVIDIA for the DRIVE AGX Thor development kit, aimed at advancing autonomous vehicle technology. The integration of QNX OS for Safety 8 with NVIDIA’s hardware is a significant step in combining automotive-certified operating systems with cutting-edge generative AI capabilities. BlackBerry also made headlines with the appointment of Barry Mainz, a seasoned cybersecurity expert, to its Board of Directors, bringing decades of experience in technology leadership. Additionally, BlackBerry’s annual shareholder meeting resulted in the election of all seven director nominees, with directors like Lisa Bahash and Lori O’Neill receiving strong approval ratings. Meanwhile, Medtronic plc appointed Chad Spooner as the CFO for its diabetes business, MiniMed, as it prepares for a spinoff. Spooner brings over 25 years of financial leadership experience, previously serving as CFO at BIC. These developments reflect ongoing strategic moves by both companies in their respective industries.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.